Physician profile
Gary A Aaronson
NPI 1770672040
$121,689.72
in general payments reported to CMS, 2019-2025
51 companies · $17K in 2025
The $17K reported for 2025 was more than what 95% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $15K · 2021: $20K · 2022: $9,278 · 2023: $14K · 2024: $29K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Food and Beverage: $13K · Education: $759 · Consulting Fee: $600 · Travel and Lodging: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44,410.00 |
| Food and Beverage | $12,964.11 |
| Education | $758.53 |
| Consulting Fee | $600.00 |
| Travel and Lodging | $344.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $81,127.63 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Insmed, INC. | $21,893.52 | 2019-2025 | Arikayce |
| Glaxosmithkline, LLC. | $3,380.74 | 2019-2025 | Trelegy Ellipta, Nucala |
| Regeneron Healthcare Solutions, INC. | $1,817.36 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,278.44 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Jazz Pharmaceuticals INC. | $1,274.15 | 2019-2025 | Xywav |
| Genzyme Corporation | $1,272.52 | 2019-2025 | |
| Harmony Biosciences LLC | $1,208.35 | 2021-2025 | Wakix |
| Actelion Pharmaceuticals US, INC. | $994.70 | 2019-2025 | Uptravi, Opsumit |
| Mylan Specialty L.P. | $954.78 | 2019-2024 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $778.00 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $576.73 | 2020-2025 | Aralast, Glassia |
| Mallinckrodt Hospital Products INC. | $478.89 | 2020-2025 | Acthar |
| Grifols USA, LLC | $473.34 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Genentech USA, INC. | $466.41 | 2019-2023 | Xolair, Esbriet |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $461.73 | 2019-2025 | Tyvaso, Tyvaso |
| Advanced Respiratory, INC | $324.19 | 2019-2021 | |
| Philips North America LLC | $316.24 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Electromed, INC. | $315.11 | 2019-2025 | Smartvest |
| Ani Pharmaceuticals, INC. | $252.81 | 2023-2025 | Purified Cortrophin Gel |
| Amgen INC. | $237.94 | 2021-2025 | Tezspire |
| Verona Pharma, INC. | $180.09 | 2025 | Ohtuvayre |
| Mallinckrodt Enterprises LLC | $175.34 | 2019 | |
| Lilly USA, LLC | $121.46 | 2025 | Zepbound |
| Inspire Medical Systems, INC. | $115.69 | 2023-2025 | Inspire |
| Merck Sharp & Dohme LLC | $100.50 | 2019-2021 | |
| Axsome Therapeutics, INC. | $89.29 | 2023-2024 | Sunosi |
| Pfizer INC. | $86.98 | 2019-2023 | |
| Baxter Healthcare | $83.41 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Sunovion Pharmaceuticals INC. | $82.12 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $78.02 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $68.34 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $62.98 | 2019-2023 | |
| Inogen, INC. | $61.87 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Vifor Pharma, INC. | $58.45 | 2024-2025 | Zemaira |
| Shire North American Group INC | $54.58 | 2019 | |
| Viatris Specialty LLC | $54.11 | 2025 | Yupelri |
| Optinose US, INC. | $37.93 | 2024 | |
| La Jolla Pharmaceutical Company | $37.18 | 2024-2025 | Xacduro |
| Nabriva Therapeutics, Plc | $32.92 | 2020 | |
| Tactile Systems Technology INC | $32.10 | 2024 | Entre Plus, Flexitouch Plus |
| Covis Pharma Gmbh | $24.66 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $23.04 | 2019 | |
| Sumitomo Pharma America, INC. | $22.54 | 2024 | Gemtesa |
| Daiichi Sankyo INC. | $22.09 | 2019 | |
| Phadia US INC. | $20.81 | 2024 | Immunocap |
| Bio Products Laboratory USA, INC. | $18.36 | 2023 | Coagadex, Gammaplex |
| Pulmonx Corporation | $17.41 | 2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Circassia INC. | $15.58 | 2019 | |
| Resmed Corp | $15.18 | 2023 | |
| Shionogi INC | $13.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Aaronson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.